Phosphatase activity in particulate fractions of rat brain. Effect of cations and biogenic amines in vitro studies.
D000109:Acetylcholine / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000469:Alkaline Phosphatase / Q000378:metabolism*; D000812:Anhydrides / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000166:cytology / Q000201:enzymology*; D002118:Calcium / Q000494:pharmacology*; D003864:Depression, Chemical; D004298:Dopamine / Q000494:pharmacology; D005988:Glyceric Acids / Q000494:pharmacology; D005994:Glycerophosphates / Q000494:pharmacology; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology*; D008297:Male; D008928:Mitochondria / Q000187:drug effects / Q000201:enzymology*; D009596:Nitrophenols / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology; D009840:Oligomycins / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology*; D051381:Rats; D013268:Stimulation, Chemical; D013501:Surface-Active Agents / Q000494:pharmacology
D000812:Anhydrides; D005988:Glyceric Acids; D005994:Glycerophosphates; D009596:Nitrophenols; D009840:Oligomycins; D010627:Phenethylamines; D013501:Surface-Active Agents; D010042:Ouabain; D000255:Adenosine Triphosphate; D000469:Alkaline Phosphatase; D008274:Magnesium; D000109:Acetylcholine; D011188:Potassium; D002118:Calcium; D004298:Dopamine; D009638:Norepinephrine